文献速递眼底病与葡萄膜炎

新生血管性年龄相关性黄斑变性放疗继发微血管异常的INTREPID试验发现

Microvascular abnormalities secondary to radiation therapy in neovascular age-related macular degeneration: findings from the INTREPID clinical trial.
PubMed 文献 · Br J Ophthalmol · 2018-06-21

SRT联合组微血管异常(MVA)发生率第1年0%、第2年13.1%、第3年30.3%,MVA面积小,第2年有MVA与无MVA亚组视力变化相似;18例第2年MVA中2例、37例第3年MVA中5例认为MVA可能促成视力下降。结论认为SRT相关MVA细微、对视力结局影响很小或无影响。

要点

  • SRT联合组MVA发生率第1年0%、第2年13.1%、第3年30.3%。
  • MVA面积小,第2年有MVA与无MVA亚组平均视力变化相似。
  • 第2年18例MVA中2例、第3年37例中5例认为MVA可能促成视力下降。

核心结论

  • SRT治疗与细微MVA发生相关,对视力结局影响很小或无影响,有助于临床医生识别SRT相关视网膜MVA。

研究设计与样本

  • 干预为16 Gy、24 Gy或假手术SRT,三组均在病灶活动时按需给予抗VEGF注射。
  • 基线与6个月彩色眼底图像、基线与每年荧光素血管造影按预设方案和定义分级,以区分RT相关MVA与非特异性视网膜血管异常。
  • 主要结局指标为入组后第12、24、36个月检测到的MVA。

主要发现

  • SRT联合组MVA频率第1年0%、第2年13.1%、第3年30.3%。
  • MVA面积小,第2年有MVA与无MVA的SRT眼亚组平均视力变化相似。
  • 第2年18例MVA中2例、第3年37例MVA中5例认为MVA可能促成视力下降。

临床怎么用

  • 研究结果可帮助临床医生识别新生血管性AMD患者接受SRT后出现的视网膜MVA。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To report the incidence and features of retinal microvascular abnormalities (MVAs) occurring secondary to stereotactic radiotherapy (SRT) in a randomised double-masked sham-controlled clinical trial at 21 European sites. METHODS: Two hundred and thirty participants with neovascular age-related macular degeneration (AMD) treated with at least three intravitreal antivascular endothelial growth factor (anti-VEGF) injections prior to enrolment, and demonstrating a continuing need for re-treatment. INTERVENTIONS: 16 Gy, 24 Gy or sham SRT. All three groups received pro re nata anti-VEGF injections if the lesion was judged to be active at review visits. Colour fundus images from baseline and 6 months and fluorescein angiograms from baseline and annual visits were graded for measures of morphological outcome and safety using a prespecified protocol with accompanying definitions to distinguish RT-related MVA from non-specific retinal vessel abnormalities that are known to occur in neovascular AMD. The main outcome measure was MVA detected by months 12, 24 and 36 after enrolment. RESULTS: The frequency of MVAs in the combined SRT arms was 0% in year 1, 13.1% in year 2 and 30.3% in year 3. The area of MVA was small and the mean change in visual acuity in year 2 was similar in a subset of SRT eyes with MVAs, versus those without MVAs. MVA was considered to have possibly contributed to vision loss in 2 of 18 cases with MVA in year 2, and 5 of 37 cases in year 3. CONCLUSION: Treatment with SRT is associated with development of subtle MVAs that have little or no impact on visual outcome. These findings can help clinicians recognise the retinal MVAs that occur in response to SRT.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Freiberg FJ, Michels S, Muldrew A, et al. Microvascular abnormalities secondary to radiation therapy in neovascular age-related macular degeneration: findings from the INTREPID clinical trial. Br J Ophthalmol. 2018. PMID: 29930098. doi:10.1136/bjophthalmol-2018-311865

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。